David Becton is an Oncology physician affiliated with Arkansas Children's Hospital. OpenAlex indexes 90 publications with 2,959 citations (h-index 28); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Marshall St # 653
Little Rock, AR 722023510
Telephone
501-364-1100Registry record last updated 31 Jul 2007.
Clinical trials
- Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Sponsor: Children's Oncology Group
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Sponsor: Children's Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
2 NIH research awards on record, funded 1987–1995 per NIH RePORTER. The latest:
- PROPHYLACTIC PENICILLIN IN SICKLE CELL DISEASE
University of Arkansas Med Scis Ltl Rock
FY1994N01HB077034
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
Journal of Personalized Medicine
2021 - Short‐term side effects and patient‐reported outcomes of bleomycin sclerotherapy in vascular malformations
Pediatric Blood & Cancer
2018 - Nutlin‐3 treatment spares cisplatin‐induced inhibition of bone healing while maintaining osteosarcoma toxicity
Journal of Orthopaedic Research®
2016
Similar KOLs
Other experts from the same institution or the same specialty.
William Steinbach, MD
Arkansas Children's Hospital
Stacie Jones, MD
Arkansas Children's Hospital
Amy Scurlock, MD
Arkansas Children's Hospital
Gresham Richter, MD
Arkansas Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”